Janus Henderson Global Life Sciences Fund Class T (JAGLX)
NASDAQ · Mutual Fund
· Delayed Price · Currency is USD
63.15
-0.08 (-0.13%)
May 27, 2025, 8:09 AM EDT
JAGLX Holdings List
As of Mar 31, 2025
No. | Symbol | Name | % Weight |
---|---|---|---|
1 | LLY | Eli Lilly and Company | 9.42% |
2 | UNH | UnitedHealth Group Incorporated | 6.89% |
3 | LON: AZN | AstraZeneca PLC | 4.02% |
4 | JNJ | Johnson & Johnson | 3.60% |
5 | BSX | Boston Scientific Corporation | 3.14% |
6 | ABT | Abbott Laboratories | 3.10% |
7 | EPA: SAN | Sanofi | 3.06% |
8 | AMGN | Amgen Inc. | 2.90% |
9 | ABBV | AbbVie Inc. | 2.83% |
10 | VRTX | Vertex Pharmaceuticals Incorporated | 2.82% |
11 | CPH: NOVO.B | Novo Nordisk A/S | 2.40% |
12 | TMO | Thermo Fisher Scientific Inc. | 2.36% |
13 | NVSN.MX | Novartis AG ADR | 2.34% |
14 | ARGX | argenx SE | 2.13% |
15 | ISRG | Intuitive Surgical, Inc. | 1.88% |
16 | SYK | Stryker Corporation | 1.79% |
17 | DHR | Danaher Corporation | 1.79% |
18 | MRK | Merck & Co., Inc. | 1.75% |
19 | MDT | Medtronic plc | 1.53% |
20 | SWX: ROG | Roche Holding AG | 1.50% |
21 | ASND | Ascendis Pharma A/S | 1.44% |
22 | SLNO | Soleno Therapeutics, Inc. | 1.40% |
23 | MCK | McKesson Corporation | 1.34% |
24 | AKRO | Akero Therapeutics, Inc. | 1.34% |
25 | HCA | HCA Healthcare, Inc. | 1.34% |
26 | MDGL | Madrigal Pharmaceuticals, Inc. | 1.31% |
27 | COR | Cencora, Inc. | 1.16% |
28 | GMED | Globus Medical, Inc. | 1.06% |
29 | RNA | Avidity Biosciences, Inc. | 1.05% |
30 | LNTH | Lantheus Holdings, Inc. | 1.04% |
31 | VRNA | Verona Pharma plc | 1.03% |
32 | ELV | Elevance Health, Inc. | 0.99% |
33 | RVMD | Revolution Medicines, Inc. | 0.93% |
34 | CVS | CVS Health Corporation | 0.84% |
35 | DXCM | DexCom, Inc. | 0.81% |
36 | TEVA | Teva Pharmaceutical Industries Limited | 0.77% |
37 | BBIO | BridgeBio Pharma, Inc. | 0.77% |
38 | ZTS | Zoetis Inc. | 0.71% |
39 | PCVX | Vaxcyte, Inc. | 0.70% |
40 | MIRM | Mirum Pharmaceuticals, Inc. | 0.68% |
41 | PEN | Penumbra, Inc. | 0.68% |
42 | EW | Edwards Lifesciences Corporation | 0.63% |
43 | ZLAB | Zai Lab Limited | 0.62% |
44 | GILD | Gilead Sciences, Inc. | 0.59% |
45 | SRPT | Sarepta Therapeutics, Inc. | 0.58% |
46 | COO | The Cooper Companies, Inc. | 0.55% |
47 | INSP | Inspire Medical Systems, Inc. | 0.55% |
48 | PTCT | PTC Therapeutics, Inc. | 0.53% |
49 | CNC | Centene Corporation | 0.49% |
50 | BHVN | Biohaven Ltd. | 0.48% |
51 | TVTX | Travere Therapeutics, Inc. | 0.48% |
52 | HUM | Humana Inc. | 0.48% |
53 | ETNB | 89bio, Inc. | 0.46% |
54 | ARDX | Ardelyx, Inc. | 0.43% |
55 | ALGN | Align Technology, Inc. | 0.43% |
56 | STE | STERIS plc | 0.42% |
57 | AVDL | Avadel Pharmaceuticals plc | 0.41% |
58 | DYN | Dyne Therapeutics, Inc. | 0.39% |
59 | TFX | Teleflex Incorporated | 0.39% |
60 | ACLX | Arcellx, Inc. | 0.39% |
61 | ALNY | Alnylam Pharmaceuticals, Inc. | 0.37% |
62 | INSM | Insmed Incorporated | 0.34% |
63 | LEGN | Legend Biotech Corporation | 0.33% |
64 | EWTX | Edgewise Therapeutics, Inc. | 0.32% |
65 | UTHR | United Therapeutics Corporation | 0.30% |
66 | JANX | Janux Therapeutics, Inc. | 0.30% |
67 | NBIX | Neurocrine Biosciences, Inc. | 0.30% |
68 | SHC | Sotera Health Company | 0.29% |
69 | NUVL | Nuvalent, Inc. | 0.29% |
70 | RYTM | Rhythm Pharmaceuticals, Inc. | 0.28% |
71 | IDYA | IDEAYA Biosciences, Inc. | 0.28% |
72 | n/a | Janus Henderson Cash Liquidity Fund Llc | 0.27% |
73 | ICLR | ICON Public Limited Company | 0.26% |
74 | XENE | Xenon Pharmaceuticals Inc. | 0.24% |
75 | CRNX | Crinetics Pharmaceuticals, Inc. | 0.24% |
76 | FOLD | Amicus Therapeutics, Inc. | 0.23% |
77 | APGE | Apogee Therapeutics, Inc. | 0.22% |
78 | GPCR | Structure Therapeutics Inc. | 0.22% |
79 | CYTK | Cytokinetics, Incorporated | 0.21% |
80 | TYO: 7741 | HOYA Corporation | 0.20% |
81 | ILMN | Illumina, Inc. | 0.19% |
82 | IQV | IQVIA Holdings Inc. | 0.18% |
83 | MTSR | Metsera, Inc. | 0.17% |
84 | NEO | NeoGenomics, Inc. | 0.16% |
85 | CGON | CG Oncology, Inc. | 0.15% |
86 | PRAX | Praxis Precision Medicines, Inc. | 0.14% |
87 | BEAM | Beam Therapeutics Inc. | 0.13% |
88 | n/a | Heartflow Inc - Series F | 0.13% |
89 | n/a | Bicara Therapeutics | 0.12% |
90 | IMNM | Immunome, Inc. | 0.12% |
91 | n/a | Curevo Inc | 0.11% |
92 | GERN | Geron Corporation | 0.09% |
93 | n/a | Attralus Inc Pp | 0.08% |
94 | RCKT | Rocket Pharmaceuticals, Inc. | 0.08% |
95 | n/a | Element Biosciences Inc Pp | 0.07% |
96 | n/a | Magnolia Medical Technologies Inc Pp - Series D | 0.07% |
97 | FDMT | 4D Molecular Therapeutics, Inc. | 0.07% |
98 | n/a | Asher Biotherapeutics - Series C | 0.06% |
99 | n/a | Shoreline Biosciences Inc Pp | 0.06% |
100 | n/a | Curevo Inc Series B-1 Usd (Private Placement) | 0.05% |
101 | LXEO | Lexeo Therapeutics, Inc. | 0.05% |
102 | n/a | Beauty Health Co/The | 0.04% |
103 | n/a | Sonoma Biotherapeutics Inc - Series B | 0.04% |
104 | EFGBNK.0 03.28.19 0005 | EFG International Finance Guernsey Ltd. | 0.04% |
105 | n/a | Freenome Holdings Inc - Series C | 0.04% |
106 | n/a | Curevo Inc Series B Usd (Private Placement) | 0.04% |
107 | n/a | Asher Biotherapeutics Inc Pp | 0.03% |
108 | n/a | Twinstrand Biosciences Inc Pp | 0.03% |
109 | n/a | Sonoma Biotherapeutics Inc - Series B-1 | 0.02% |
110 | BCAX | Bicara Therapeutics Inc. | 0.01% |
111 | n/a | Magnolia Medical Technologies Series E1 Usd | 0.01% |
112 | n/a | Magnolia Medical Technologies C/Wts Usd.001 | 0.00% |
113 | n/a | Clementia Pharmaceuticals Inc | 0.00% |
As of Mar 31, 2025